Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Start 7-day free trial → Log in

Milvexian · BMS-986177

Small molecule · developed by BRISTOL MYERS SQUIBB

Phase 3 Most advanced trial

BMY Developer

1 Registered trials

What is Milvexian?

Milvexian is an oral small-molecule drug studied in ischemic stroke and transient ischemic attack.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as: BMS-986177, JNJ-70033093, BMS-986177
Drug type: Small molecule
Therapy area: Cardiovascular
Developer: BRISTOL MYERS SQUIBB (BMY)
FDA status: Investigational, not approved in the US. Most advanced trial: Phase 3
UNII: 0W79NDQ608

🧪 Clinical trials

Trial	Phase	Condition	Status	Sponsor
NCT05702034	Phase 3	Ischemic Stroke; Ischemic Attack, Transient	Active not recruiting	BMY

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Ischemic Stroke; Ischemic Attack, Transient

More from BRISTOL MYERS SQUIBB

Apixaban FDA approved Belatacept FDA approved Deucravacitinib FDA approved Ipilimumab FDA approved Lisocabtagene Maraleucel FDA approved Luspatercept FDA approved Mavacamten FDA approved Nab-paclitaxel FDA approved Nivolumab FDA approved Ozanimod FDA approved Relatlimab FDA approved Repotrectinib FDA approved

Sources

ClinicalTrials.gov NCT05702034

Updated Oct 3, 2026. Something wrong or missing? Report it on the BMY page.

Follow BMY, the company behind Milvexian

See BMY's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

BMY catalysts and pipeline →

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z